Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease

BACKGROUND: Patients with steroid-refractory acute graft-versus-host disease (aGvHD) not tolerating/responding to ruxolitinib (RR-aGvHD) have a dismal prognosis. METHODS: We retrospectively assessed real-world outcomes of RR-aGvHD treated with the random-donor allogeneic MSC preparation MSC-FFM, ava...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonig, Halvard, Verbeek, Mareike, Herhaus, Peter, Braitssch, Krischan, Beutel, Gernot, Schmid, Christoph, Müller, Nadine, Bug, Gesine, Döring, Michaela, von Stackelberg, Arend, Tischer, Johanna, Ayuk, Francis, Wulf, Gerald, Holtick, Udo, Pfeffermann, Lisa-Marie, Jahrsdörfer, Bernd, Schrezenmeier, Hubert, Kuci, Selim, Kuci, Zyrafete, Zens, Anke, Tribanek, Michael, Zeiser, Robert, Huenecke, Sabine, Bader, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664468/
https://www.ncbi.nlm.nih.gov/pubmed/37990219
http://dx.doi.org/10.1186/s12967-023-04731-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664468/
https://www.ncbi.nlm.nih.gov/pubmed/37990219
http://dx.doi.org/10.1186/s12967-023-04731-1

Ejemplares similares